Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development.
| Website | http://www.inoviv.com |
| Employees | 20 (15 on RocketReach) |
| Founded | 2017 |
| Phone | +44 20 3290 1587 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+10 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Biomarker Discovery, Biomarker Research, Pharmaceutical Development, Biomarker Validation, Diagnostics Development, Test Development, Drug Development, Therapeutic Development, Clinical Diagnostics, Platform Technology, Precision Medicine, Novel Technology, Pharmaceutical Research, Drug Discovery, Clinical Research |
| Competitors | Roche, Illumina, Tempus Labs, Inc., Guardant Health, Foundation Medicine, Caris Life Sciences, Invitae, NantHealth, PathAI, Biocept, Inc. +44 more (view full list) |
Looking for a particular Inoviv employee's phone or email?
Marie Labus is the CEO of Inoviv.
15 people are employed at Inoviv.